AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
RISPERIDONE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CP-RISPERIDONE TABLET, COATED; ORAL | 2026/13.2.3/7426 | COSPHARM INVESTMENTS PVT LTD | active | 10 May 2031 |
| NONE TABLET, COATED; ORAL | 2026/13.2.3/7388 | UTANO GROUP FZC | active | 14 Apr 2031 |
| NONE TABLET, COATED; ORAL | 2026/13.2.3/7389 | UTANO GROUP FZC | active | 14 Apr 2031 |
| RISPONSE 1 TABLET; ORAL | 2020/13.2.3/6011 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| RISPONSE 2 TABLET; ORAL | 2020/13.2.3/6012 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
RISPERIDONE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing RISPERIDONE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track RISPERIDONE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.